Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enavogliflozin Phase 2 in Type 2 Diabetes
NCT04014023Phase 2Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enavogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
enavogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04014023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04014023.